Periprocedural Myocardial Injury and Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve

Misha Dagan1, Luke P Dawson2, Julia Stehli1

  • 1Department of Cardiology, Alfred Hospital, Victoria, Australia.

Abstract

Insights

Peri-procedural myocardial injury (PPMI) is common after transcatheter aortic valve replacement (TAVR) but not linked to mortality. Incidental coronary artery disease (iCAD) treated with percutaneous coronary intervention (PCI) may reduce long-term mortality in TAVR patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Peri-procedural myocardial injury (PPMI) and incidental coronary artery disease (iCAD) are frequent in patients undergoing transcatheter aortic valve replacement (TAVR).
  • Existing research on the impact of PPMI and iCAD on TAVR outcomes lacks definitive consensus.
  • This study investigates the influence of PPMI and iCAD on long-term mortality following TAVR.

Purpose of the Study:

  • To determine the incidence of PPMI and iCAD in patients undergoing TAVR.
  • To evaluate the association between PPMI and iCAD with long-term mortality after TAVR.
  • To explore factors associated with PPMI and the impact of percutaneous coronary intervention (PCI) for iCAD on TAVR outcomes.

Main Methods:

  • Prospective analysis of 400 patients undergoing TAVR for severe aortic stenosis (2008-2018).
  • PPMI defined as troponin 15× ULN; iCAD defined as ≥50% coronary stenosis (excluding prior CABG).
  • Multivariable logistic regression used to identify predictors of PPMI and assess the impact of iCAD and PCI on mortality.

Main Results:

  • PPMI occurred in 65% of patients, associated with higher LVEF and first-generation valves, but not mortality.
  • iCAD was present in 40% of patients (after excluding prior CABG).
  • Percutaneous coronary intervention (PCI) for iCAD was associated with reduced long-term mortality compared to medical management (aOR 0.37; P=0.03).

Conclusions:

  • PPMI is common post-TAVR and linked to specific patient/procedural factors but not long-term mortality.
  • iCAD is prevalent in TAVR patients and PCI intervention may improve long-term survival.
  • These findings highlight the importance of managing iCAD in TAVR candidates.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
414
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
328
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
105
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
133
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
147
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
152